Initiating Urate-Lowering Therapy with Colchicine and Allopurinol

Treatment Strategy for Acute Gout Flare

• The American College of Physicians recommends treating the acute flare first with colchicine, NSAIDs, or corticosteroids, and starting allopurinol concurrently, with colchicine serving as prophylaxis against flare recurrence 1, 2
• Colchicine should be continued prophylactically at 0.5-1.0 mg daily after treating the acute attack, as recommended by the American College of Rheumatology 3, 2

FDA-Approved Dosing and Evidence Supporting Concurrent Initiation

• The American College of Physicians recommends continuing prophylaxis for at least 6 months, with moderate-quality evidence supporting this duration 1, 2, 4

Critical Safety Considerations Before Starting Colchicine

• The European League Against Rheumatism recommends avoiding colchicine in patients with severe renal impairment (GFR <30 mL/min) due to decreased clearance 4, 5
• The American College of Clinical Pharmacy recommends dose adjustments for moderate renal impairment (CrCl 30-50 mL/min) and monitoring closely 4, 5

Common Pitfalls to Avoid

• The American College of Rheumatology recommends continuing prophylaxis for at least 6 months, or longer if flares persist or serum urate target not achieved, to avoid inadequate prophylaxis duration 1, 2, 4
• The European League Against Rheumatism recommends reviewing medication lists for CYP3A4/P-gp inhibitors before prescribing colchicine to avoid drug interactions 4, 5